YWHAZ Gene

YWHAZ Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">YWHAZ Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>YWHAZ</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Zeta/Delta</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q23.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7534</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000164924</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63169</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>603551</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Association Type</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Modifier/Biomarker</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Amyotrophic Lateral Sclerosis</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Huntington's Disease</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">ζ/δ</td>
<td>YWHAZ</td>
</tr>
<tr>
<td class="label">σ</td>
<td>SFN</td>
</tr>
<tr>
<td class="label">β</td>
<td>YWHAB</td>
</tr>
<tr>
<td class="label">γ</td>
<td>YWHAG</td>
</tr>
<tr>
<td class="label">η</td>
<td>YWHAH</td>
</tr>

YWHAZ Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">YWHAZ Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>YWHAZ</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Zeta/Delta</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>8q23.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>7534</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000164924</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P63169</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>603551</td>
</tr>
<tr>
<td class="label">Disease</td>
<td>Association Type</td>
</tr>
<tr>
<td class="label">Alzheimer's Disease</td>
<td>Modifier/Biomarker</td>
</tr>
<tr>
<td class="label">Parkinson's Disease</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Amyotrophic Lateral Sclerosis</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Huntington's Disease</td>
<td>Modifier</td>
</tr>
<tr>
<td class="label">Isoform</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">ζ/δ</td>
<td>YWHAZ</td>
</tr>
<tr>
<td class="label">σ</td>
<td>SFN</td>
</tr>
<tr>
<td class="label">β</td>
<td>YWHAB</td>
</tr>
<tr>
<td class="label">γ</td>
<td>YWHAG</td>
</tr>
<tr>
<td class="label">η</td>
<td>YWHAH</td>
</tr>
<tr>
<td class="label">ε</td>
<td>YWHAE</td>
</tr>
<tr>
<td class="label">τ</td>
<td>YWHAQ</td>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">RAF</td>
<td>Binding/Regulation</td>
</tr>
<tr>
<td class="label">AKT</td>
<td>Binding/Activation</td>
</tr>
<tr>
<td class="label">PKC</td>
<td>Binding/Localization</td>
</tr>
<tr>
<td class="label">CK2</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">GSK3β</td>
<td>Binding/Inhibition</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">66 edges</a></td>
</tr>
</table>

The YWHAZ gene (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Zeta) encodes the zeta/delta isoform of 14-3-3 proteins. This is one of the most widely expressed 14-3-3 isoforms and plays critical roles in cell survival, signal transduction, and neuronal function. [@yau2015]

Pathway / Interaction Diagram

Gene Information

Function

YWHAZ encodes 14-3-3 zeta/delta, a versatile adaptor protein:

• [Apoptosis](/entities/apoptosis) Suppression: Binds to and inhibits pro-apoptotic proteins including BAD, BAX, and FOXO transcription factors
• Signal Transduction: Critical regulator of MAPK, PI3K/Akt, and other signaling pathways
• Neuronal Survival: Protects [neurons](/entities/neurons) from various apoptotic stimuli
• Synaptic Function: Modulates neurotransmitter release and synaptic plasticity
• mRNA Localization: Involved in dendritic mRNA transport and local translation

Disease Associations

Neurodegenerative Diseases

Cancer

• Oncogenic Role: 14-3-3 zeta is frequently overexpressed in cancers and promotes tumor progression

Expression

YWHAZ is expressed ubiquitously with high expression in:

• Cerebral [cortex](/brain-regions/cortex)
• [Hippocampus](/brain-regions/hippocampus)
• [Cerebellum](/brain-regions/cerebellum)
• Most brain regions

Key Publications

See Also

• [14-3-3 Proteins](/entities/14-3-3-proteins)
• [YWHAZ Protein](/proteins/ywhaz-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [NCBI Gene: YWHAZ](https://www.ncbi.nlm.nih.gov/gene/7534)
• [UniProt: P63169](https://www.uniprot.org/uniprotkb/P63169/)
• [OMIM: YWHAZ](https://www.omim.org/entry/603551)
• [Ensembl: YWHAZ](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000164924)

Molecular Mechanisms

14-3-3 Protein Structure and Function

The 14-3-3 protein family consists of seven isoforms (β, ε, η, γ, σ, ζ/δ, τ) that function as adaptor proteins mediating protein-protein interactions. 14-3-3 proteins recognize specific phosphoserine/phosphothreonine motifs on their targets, enabling them to regulate diverse cellular processes. [@steinacker2011]

The ζ/δ isoform encoded by YWHAZ is characterized by:

• [A conserved amphipathic groove that binds phosphorylated target pr](/genes/ar)oteins
• Dimerization capability enabling simultaneous binding of multiple targets
• Tissue-specific expression patterns with high abundance in neural tissue

Neuroprotective Mechanisms in Neurodegeneration

Tau Pathology Interaction

14-3-3 ζ interacts with tau protein through multiple mechanisms:

• Direct binding to phosphorylated tau at specific epitopes
• Modulation of tau phosphorylation by protein kinases and phosphatases
• Involvement in tau aggregation and fibril formation pathways
• Potential role in neurofibrillary tangle formation in AD [@umahara2004]

Alpha-Synuclein Modulation

In Parkinson's disease, 14-3-3 ζ may influence alpha-synuclein pathology:

• Binding to alpha-synuclein aggregates
• Modulation of cellular clearance mechanisms
• Regulation of oxidative stress responses in dopaminergic neurons

Neuroinflammation Regulation

14-3-3 proteins modulate neuroinflammatory responses:

• Regulation of glial cell activation
• Modulation of cytokine production
• Control of blood-brain barrier integrity

Therapeutic Implications

Biomarker Potential

CSF and plasma 14-3-3 ζ levels show promise as biomarkers:

• Elevated CSF 14-3-3 in Creutzfeldt-Jakob disease (established biomarker)
• Potential utility in Alzheimer's disease progression monitoring
• Research ongoing for Parkinson's disease applications [@benzinger2005]

Therapeutic Targeting

Strategies targeting 14-3-3 protein interactions:

• Small molecule inhibitors of 14-3-3 protein-protein interactions
• Peptide-based disruptors of 14-3-3 binding
• Gene therapy approaches to modulate 14-3-3 expression

14-3-3 Protein Family Overview

Neurodegenerative Disease Mechanisms

Alzheimer's Disease

In AD, 14-3-3 ζ plays complex roles:

• Elevated in AD brain tissue and CSF
• Interacts with tau phosphorylation machinery
• May contribute to synaptic dysfunction
• Potential compensatory neuroprotective response

Parkinson's Disease

14-3-3 ζ alterations in PD:

• Changes in 14-3-3 isoform expression in substantia nigra
• Interaction with parkin and PINK1 mitophagy pathways
• Potential role in dopaminergic neuron survival

Amyotrophic Lateral Sclerosis

In ALS:

• 14-3-3 proteins interact with TDP-43 pathology
• Modulation of FUS protein aggregation
• Involvement in RNA metabolism pathways

Huntington's Disease

14-3-3 ζ in HD:

• Modulates mutant huntingtin aggregation
• Regulates cellular stress responses
• Potential therapeutic target

Signaling Pathway Interactions

MAPK/ERK Pathway

14-3-3 ζ regulates MAPK signaling:

• Binds to and regulates RAF kinases
• Controls MEK and ERK activation
• Influences neuronal differentiation and survival

PI3K/Akt Pathway

14-3-3 proteins regulate Akt signaling:

• Controls Akt subcellular localization
• Modulates Akt activation by growth factors
• Neuroprotective effects through Akt pathway

Mitochondrial Function

14-3-3 ζ influences mitochondrial biology:

• Regulation of mitochondrial dynamics
• Control of apoptosis executors
• Modulation of mitochondrial quality control

Research Directions

Emerging Areas

• Phosphorylation effects on target binding
• Acetylation impacts on protein function
• Ubiquitination and degradation pathways

• Hippocampal synaptic plasticity roles
• Cortical neuron survival mechanisms
• Cerebellar functions

• Shared pathways in protein aggregation diseases
• Common therapeutic targets
• Biomarker cross-disease applications

Clinical Trials and Therapeutics

Current therapeutic approaches targeting 14-3-3:

• Preclinical validation of 14-3-3 modulators
• Peptide-based therapeutic candidates
• Gene therapy vectors for 14-3-3 regulation

Gene Variation and Disease Risk

Known Variants

YWHAZ genetic variations:

• Association studies with neurodegenerative disease risk
• Expression quantitative trait loci (eQTLs) in brain tissue
• Potential modifier of disease progression

Population Genetics

• YWHAZ conservation across species
• Evolutionary analysis of 14-3-3 family
• Species-specific expression patterns

Detailed Molecular Pathways

14-3-3 Zeta in Neuronal Apoptosis

The 14-3-3 ζ protein plays a critical role in regulating neuronal apoptosis through multiple mechanisms. As an adaptor protein, it binds to and sequesters pro-apoptotic proteins, thereby preventing their translocation to mitochondria and subsequent cytochrome c release. This anti-apoptotic function is particularly important in post-mitotic neurons, which are highly vulnerable to apoptotic stimuli. [@kim2020]

The molecular mechanisms include:

Synaptic Transmission Modulation

14-3-3 ζ is enriched at synaptic terminals where it modulates neurotransmitter release:

• Presynaptic Functions: Regulates vesicle docking and fusion machinery
• Postsynaptic Effects: Modulates receptor trafficking and signaling
• Synaptic Plasticity: Involved in LTP and LTD processes
• Dendritic Spines: Controls spine morphology and stability

• Syntaxin
• SNAP-25
• Synapsin
• NMDA and AMPA receptor subunits

Calcium Signaling Regulation

14-3-3 ζ plays important roles in calcium signaling:

• Calcium Homeostasis: Modulates calcium influx through voltage-gated channels
• Calmodulin Binding: Interacts with calcium-bound calmodulin
• ER Calcium Release: Regulates IP3 receptor function
• Mitochondrial Calcium: Controls mitochondrial calcium uptake

Protein Kinase Interactions

14-3-3 ζ interacts with numerous protein kinases:

Neurodegenerative Disease Context

Alzheimer's Disease: Molecular Mechanisms

In Alzheimer's disease, 14-3-3 ζ undergoes significant alterations:

Expression Changes:

• Increased expression in AD brain, particularly in affected regions
• Elevated CSF levels correlating with disease severity
• Colocalization with amyloid plaques and neurofibrillary tangles

• Compensatory neuroprotective response to amyloid toxicity
• Modulation of tau phosphorylation through kinase/phosphatase regulation
• Potential biomarker for disease progression

• 14-3-3 ζ as biomarker candidate
• Modulation of 14-3-3 interactions as therapeutic strategy
• Understanding tau-14-3-3 relationships for drug development

Parkinson's Disease: Molecular Mechanisms

14-3-3 ζ alterations in PD include:

Substantia Nigra Changes:

• Decreased 14-3-3 ζ in dopaminergic neurons
• Loss correlated with dopaminergic cell death
• Interaction with PD-related proteins (α-synuclein, parkin, PINK1)

• Binding to phosphorylated α-synuclein
• Modulation of mitophagy pathway proteins
• Regulation of DJ-1 oxidative stress response

• 14-3-3 ζ boosting strategies
• Small molecule stabilizers of 14-3-3-protein interactions
• Gene therapy approaches

Amyotrophic Lateral Sclerosis: Molecular Mechanisms

In ALS, 14-3-3 proteins interact with TDP-43 pathology:

TDP-43 Interactions:

• 14-3-3 proteins bind to hyperphosphorylated TDP-43
• May influence TDP-43 aggregation
• Implicated in RNA metabolism dysregulation

• Interactions with FUS protein mutations
• Modulation of nuclear-cytoplasmic transport
• RNA granule dynamics

• Targeting 14-3-3-TDP-43 interactions
• Modulating RNA metabolism
• Neuroprotective strategies

Huntington's Disease: Molecular Mechanisms

14-3-3 ζ in Huntington's disease:

Mutant Huntingtin Interactions:

• Binding to mutant huntingtin protein
• Modulation of aggregation pathways
• Influence on neuronal toxicity

• 14-3-3 modulators for HD
• Understanding protein aggregation
• Neuroprotective strategies

Cellular and Systems Neuroscience

Blood-Brain Barrier Regulation

14-3-3 ζ plays important roles in BBB function:

• Endothelial Cell Function: Regulates tight junction proteins
• Transport Modulation: Controls transporter expression and activity
• Immune Cell Trafficking: Modulates leukocyte endothelial interactions
• BBB Dysfunction: Implications for neuroinflammatory diseases

Glial Cell Interactions

The protein influences glial cell function:

Astrocytes:

• Regulation of astrocytic glutamate uptake
• Modulation of water homeostasis (AQP4 interaction)
• Support of neuronal metabolism

• Control of microglial activation states
• Regulation of cytokine production
• Phagocytosis modulation

• Myelin formation support
• Oligodendrocyte precursor cell differentiation
• White matter integrity

Circadian Rhythm Regulation

14-3-3 ζ connects to circadian clock mechanisms:

• BMAL1/CLOCK Interactions: Modulates circadian transcription factors
• SCN Function: Regulates suprachiasmatic nucleus neurons
• Sleep-Wake Cycles: Influences circadian rhythm stability
• Disease Implications: Links to circadian dysfunction in neurodegeneration

Experimental Methods and Techniques

Detection and Quantification

Protein Detection Methods:

• Western blotting for protein expression
• Immunohistochemistry for tissue localization
• ELISA for CSF and plasma levels
• Mass spectrometry for proteomics

• Co-immunoprecipitation for protein interactions
• GST pulldown assays
• Fluorescence resonance energy transfer (FRET)
• Proximity ligation assays (PLA)

Model Systems

Cell Culture Models:

• Primary neuronal cultures
• Induced pluripotent stem cells (iPSCs)
• Neuroblastoma cell lines (SH-SY5Y, SK-N-SH)
• Astrocyte and microglia cultures

• Transgenic mice overexpressing 14-3-3 ζ
• Knockout mice
• Zebra fish models
• Drosophila melanogaster models

Therapeutic Development Approaches

Small Molecule Modulators:

• 14-3-3 protein-protein interaction inhibitors
• Stabilizers of 14-3-3-target complexes
• Blood-brain barrier permeable compounds

• Cell-penetrating peptides
• Stapled peptides for improved stability
• Mimetics of 14-3-3 binding motifs

• AAV-mediated 14-3-3 ζ delivery
• siRNA approaches for knockdown
• CRISPR-based editing

Clinical Perspectives

Biomarker Development

CSF Biomarkers:

• 14-3-3 ζ as marker for prion diseases (established)
• Potential for AD progression monitoring
• PD diagnostic utility under investigation

• Plasma 14-3-3 ζ measurements
• Exosome-associated 14-3-3
• Multiplex biomarker panels

• PET ligand development for 14-3-3
• Correlation with other imaging markers

Clinical Trials

Completed Trials:

• 14-3-3 immunotherapy approaches
• Small molecule modulators

• Biomarker validation studies
• Pharmacodynamic marker development

• Disease-modifying therapeutic approaches
• Combination therapies
• Personalized medicine applications

Summary and Conclusions

The YWHAZ gene encoding 14-3-3 ζ represents a critical nexus in neuronal survival and neurodegeneration. Its diverse functions in apoptosis regulation, synaptic transmission, and cellular signaling make it both a potential biomarker and therapeutic target. While significant progress has been made in understanding 14-3-3 biology, many questions remain regarding its precise role in different neurodegenerative diseases and how to effectively modulate its functions for therapeutic benefit.

Key Takeaways:

Research Priorities:

• Understanding disease-specific mechanisms
• Developing brain-penetrant modulators
• Validating biomarker utility
• Translating preclinical findings to clinical applications

References

Pathway Diagram

The following diagram shows the key molecular relationships involving YWHAZ Gene discovered through SciDEX knowledge graph analysis: